prikaz prve stranice dokumenta PRISTUP BOLESNIKU S NEALKOHOLNOM MASNOM BOLESTI JETRE
  Download
PDF 646.84 KB
Professional paper - Review paper
PRISTUP BOLESNIKU S NEALKOHOLNOM MASNOM BOLESTI JETRE
Liječnički vjesnik, 138 (2016), 5-6; 159-163. urn:nbn:hr:184:756659
Mikolašević, Ivana; Orlić, Lidija; Štimac, Davor; Mavrinac, Vojko; Colić, Marina; Ostojić, Daniela; Milić, Sandra

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Mikolašević, I., Orlić, L., Štimac, D., Mavrinac, V., Colić, M., Ostojić, D. & Milić, S. (2016). PRISTUP BOLESNIKU S NEALKOHOLNOM MASNOM BOLESTI JETRE. Liječnički vjesnik, 138. (5-6), 159-163. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:756659

Mikolašević, Ivana, et al. "PRISTUP BOLESNIKU S NEALKOHOLNOM MASNOM BOLESTI JETRE." Liječnički vjesnik, vol. 138, no. 5-6, 2016, pp. 159-163. https://urn.nsk.hr/urn:nbn:hr:184:756659

Mikolašević, Ivana, Lidija Orlić, Davor Štimac, Vojko Mavrinac, Marina Colić, Daniela Ostojić and Sandra Milić. "PRISTUP BOLESNIKU S NEALKOHOLNOM MASNOM BOLESTI JETRE." Liječnički vjesnik 138, no. 5-6 (2016): 159-163. https://urn.nsk.hr/urn:nbn:hr:184:756659

Mikolašević, I., et al. (2016) 'PRISTUP BOLESNIKU S NEALKOHOLNOM MASNOM BOLESTI JETRE', Liječnički vjesnik, 138(5-6), pp. 159-163. Available at: https://urn.nsk.hr/urn:nbn:hr:184:756659 (Accessed 09 November 2024)

Mikolašević I, Orlić L, Štimac D, Mavrinac V, Colić M, Ostojić D, and sur.. PRISTUP BOLESNIKU S NEALKOHOLNOM MASNOM BOLESTI JETRE. Liječnički vjesnik [Internet]. 2016 [cited 2024 November 09];138(5-6):159-163. Available at: https://urn.nsk.hr/urn:nbn:hr:184:756659

I. Mikolašević, et al., "PRISTUP BOLESNIKU S NEALKOHOLNOM MASNOM BOLESTI JETRE", Liječnički vjesnik, vol. 138, no. 5-6, pp. 159-163, 2016. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:756659. [Accessed: 09 November 2024]

Metadata
Title (croatian)PRISTUP BOLESNIKU S NEALKOHOLNOM MASNOM BOLESTI JETRE
Title (english)APPROACH TO THE PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE
AuthorIvana Mikolašević
AuthorLidija Orlić
AuthorDavor Štimac
AuthorVojko Mavrinac
AuthorMarina Colić
AuthorDaniela Ostojić
AuthorSandra Milić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (croatian)
Nealkoholna masna bolest jetre (engl. nonalcoholic fatty liver disease – NAFLD) čest je uzrok aletiranih jetrenih parametara. Povezanost između masne jetre i metaboličkog sindroma (MS) dobro je dokumentirana i široko prihvaćena. Ciroza kao posljedica nealkoholnog steatohepatitisa (NASH) trenutačno je druga najčešća indikacija za liječenje transplantacijom jetre u SAD-u, a pretpostavlja se da će do 2030. postati i glavnom indikacijom za transplantaciju jetre. Gastroenterolozi/hepatolozi, kao i liječnici obiteljske medicine imaju više pitanja nego odgovora kada je u pitanju NAFLD. Najčešća su pitanja koji bolesnici s NAFLD-om imaju rizik od progresije u NASH, fi brozu, cirozu jetre i hepatocelularni karcinom te kojim bolesnicima s NAFLD-om trebamo učiniti biopsiju jetre. Osim toga sve je više neinvazivnih dijagnostičkih metoda u pristupu bolesniku s NAFLD-om. Kako pristupiti ovim bolesnicima u svakodnevnoj kliničkoj praksi postalo je više umjetnost nego znanost u ovom trenutku. U ovome preglednom radu pokušat ćemo pružiti recentne preporuke kako pristupiti bolesniku s NAFLD-o
Abstract (english)
Nonalcoholic fatty liver disease (NAFLD) has become a common cause of elevated liver tests. The association between fatty liver and metabolic syndrome (MS) is well documented and widely accepted. Cirrhosis due to nonalcoholic steatohepatitis (NASH) is currently the second most common indication for liver transplant with increasing incidence. Gastroenterologists/hepathologists and primary care physicians have more questions than answers regarding the NAFLD. The most common questions are which NAFLD patients have a risk of progression to NASH, fi brosis, cirrhosis and hepatocellular carcinoma, and which patients with NAFLD have a need for liver biopsy. In addition, a number of non-invasive diagnostic methods in the approach to the patient with NAFLD are investigated. How to approach these patients in routine clinical practice, is more of an art than a science at this time. In this article we will try to provide more recent recommendations of how to approach the patients with NAFLD
Keywords (croatian)
Keywords (english)
Languagecroatian
Publication typeProfessional paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleLiječnički vjesnik
Numberingvol. 138, no. 5-6, pp. 159-163
p-ISSN0024-3477
e-ISSN1849-2177
URN:NBNurn:nbn:hr:184:756659
Publication2016
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) icon
Created on2021-03-12 17:57:32